Arcus Biosciences Cash from Investing (TTM) Analysis

Arcus Biosciences Inc (RCUS)

16.16 +0.90 (+5.90%) USD | NYSE | May 09, 16:00

16.16 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	194.00M
September 30, 2023	213.00M
June 30, 2023	225.00M
March 31, 2023	-16.00M
December 31, 2022	-413.00M
September 30, 2022	-441.22M
June 30, 2022	-552.83M
March 31, 2022	-334.83M
December 31, 2021	-4.00M
September 30, 2021	-22.65M
June 30, 2021	-321.15M
March 31, 2021	-411.23M
December 31, 2020	-434.00M

Date	Value
September 30, 2020	-446.24M
June 30, 2020	-28.76M
March 31, 2020	84.99M
December 31, 2019	59.21M
September 30, 2019	73.83M
June 30, 2019	-39.87M
March 31, 2019	-82.67M
December 31, 2018	-113.44M
September 30, 2018	-158.02M
June 30, 2018	-61.95M
March 31, 2018	-49.07M
December 31, 2017	-49.07M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-552.83M

Minimum

Jun 2022

225.00M

Maximum

Jun 2023

-137.67M

Average

-28.76M

Median

Jun 2020

Cash from Investing (TTM) Benchmarks